Duopharma Biotech Berhad (KLSE:DPHARMA)
1.300
-0.010 (-0.76%)
At close: Aug 14, 2025
Duopharma Biotech Berhad Market Cap
Duopharma Biotech Berhad has a market cap or net worth of 1.26 billion as of August 14, 2025. Its market cap has increased by 9.17% in one year.
Market Cap
1.26B
Enterprise Value
1.50B
Revenue
883.47M
Ranking
n/a
PE Ratio
17.27
Stock Price
1.30
Market Cap Chart
Since August 27, 2002, Duopharma Biotech Berhad's market cap has increased from 187.00M to 1.26B, an increase of 573.88%. That is a compound annual growth rate of 8.66%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 14, 2025 | 1.25B | 4.00% |
Dec 31, 2024 | 1.20B | -0.79% |
Dec 29, 2023 | 1.21B | -20.94% |
Dec 30, 2022 | 1.53B | -3.10% |
Dec 31, 2021 | 1.58B | -33.70% |
Dec 31, 2020 | 2.39B | 145.56% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Malayan Banking Berhad | 119.12B |
Public Bank Berhad | 85.75B |
Tenaga Nasional Berhad | 80.44B |
CIMB Group Holdings Berhad | 77.34B |
IHH Healthcare Berhad | 61.07B |
Press Metal Aluminium Holdings Berhad | 46.22B |
Celcomdigi Berhad | 45.05B |
Hong Leong Bank Berhad | 40.38B |